Skip to main content
. 2016 Oct 5;11(10):e0163109. doi: 10.1371/journal.pone.0163109

Fig 4.

Fig 4

A.T = 1 month (60°C) TNF binding assay of reconstituted freeze-dried in vials Infliximab formulations after storage for 1 month at 60°C. Control: Infliximab (AIMM, stored at 4°C), Freeze-dried (vials): sucrose-based (F1), sucrose-inulin (F2) and sucrose-dextran (F3). B.T = 1 month (60°C) TNF binding assay of reconstituted freeze-dried Lyoguard trays Infliximab formulations after storage for1 month at 60°C. Control: Infliximab (AIMM, stored at 4°C), Freeze-dried (Lyoguard trays): sucrose-inulin (L2) and sucrose-dextran (L3). C. T = 1 month (60°C) TNF binding assay of reconstituted spray-dried Infliximab formulations after storage for1 month at 60°C. Control: Infliximab (AIMM, stored at 4°C), Spray–dried: sucrose-inulin (S1) and sucrose-dextran (S2).